At its March meeting, the European Medicines Agency’s management board adopted the EMA’s annual report for 2024. This ...

Japan’s Shionogi (TYO: 4507) yesterday delivered a late-breaking scientific oral presentation at the Conference of ...

The study, named A randomized cross-over trial of daridorexant for the treatment of chronic insomnia and nocturia, is a ...

Japanese drugmaker Seikagaku Corporation (TYO: 4548) announced that it has received a complete response letter (CRL) from the ...

US pre-clinical biotech start-up Montara Therapeutics, which is pioneering brain-selective therapies for CNS diseases, has ...

US biotech major Amgen has announced new data from the Phase III MINT trial of Uplizna (inebilizumab-cdon) in adults living with generalized myasthenia gravis (gMG).

MeiraGTx (Nasdaq: MGTX) has entered into a strategic partnership with artificial intelligence firm Hologen to accelerate the ...

Ireland-based Mallinckrodt Pharmaceuticals and Endo Inc (OTCQX: NDOI) have agreed to combine in a stock and cash deal worth ...

Privately-held Swedish firm Salipro Biotech AB, a specialist in the stabilization of challenging drug targets, today ...

UK-based Sareum Holdings, a biotech developing kinase inhibitors for autoimmune disease and cancer, has acquired the licence ...

Hours before his confirmation hearing, the Trump Administration pulled the nomination of Dr Dave Weldon to be the director of the Centers for Disease Control and Prevention (CDC).

Prague headquartered clinical-stage firm SOTIO Biotech, which is owned by the Czech Republic's PPF Group, today announced it ...